Published 2 years ago • loading... • Updated 2 years ago

Researcher identifies new biomarker of early-stage Alzheimer's disease

Summary by Medical Xpress

University of New Mexico neurologist Rawan Tarawneh, MD, has identified a unique biomarker that could lead to new diagnostic tests to improve the detection of incipient Alzheimer's disease before symptoms appear.

2 Articles

All

Left

Center

Right

Medical Xpress

Researcher identifies new biomarker of early-stage Alzheimer's disease

2 years ago

Read Full Article

DAIC

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD, have been reported by G3 Therapeutics (Global Genomics Group) and Aitia. The findings imply that LDL-TG could be a novel diagnostic marker for ASCAD and could also open up potential novel treatment targets for atherosclerosis, focusing on triglyceride-rich LDL particles.

2 years ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left0Leaning Right0Center0Last Updated2 years agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

DAIC broke the news in 2 years ago on Wednesday, February 8, 2023.

Sources are mostly out of (0)

Researcher identifies new biomarker of early-stage Alzheimer's disease

2 Articles

2 Articles

Researcher identifies new biomarker of early-stage Alzheimer's disease

Research Identifies Potential New Biomarkers of Atherosclerotic Coronary Artery Disease

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics